The Charles T. Campbell Eye Microbiology Lab
UPMCUniversity of Pittsburgh Schools of the Health Sciences
HomeContact InformationLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchPhotos

Ocular Microbiology and Immunology Group
Back to OMIG Main Page

2023 OMIG Meeting Agenda

Ocular Microbiology and Immunology Group
57th Annual Meeting
November 3, 2023

Irene C. Kuo, MD, and Jennifer Rose-Nussbaumer, MD

CLICK on titles to view abstracts
6:45 a.m. Registration
7:30 a.m. Introduction by Moderators
7:35 a.m.

2022 Harry Hirsch Leiter Award Recipient:
Genipin Corneal Crosslinking Treatment in a Fusarium solani Keratitis Model
Marcela Huertas-Bello  

7:42 a.m. 1. Adjunctive Treatment with Rose Bengal Photodynamic Antimicrobial Therapy for Patients with Progressive Infectious Keratitis: Outcomes of the First 100 Patients
Jordan Huang, MD, BHSc
7:49 a.m.

2. 222 nm UV Light Efficacy Against Fungal Species and Safety for Donor Corneal Endothelium
Andres Serrano, MD

7:56 a.m. 3. A Retrospective Analysis of the Outcomes of Conjunctival Flaps used to treat Infectious Corneal Ulcers
Christina N. Llaneras, BS
8:03 a.m. 4. Vision-Related Quality of Life Outcomes in Patients Treated for Filamentous Fungal Keratitis in the CLAIR Trial
Alejandro Arboleda
8:10 a.m. 5. Trends and Clinical Outcomes of Fungal Keratitis in Canada: A 20-year Retrospective Multicentre Study
Jennifer Ling, MSc, MD
8:17 a.m.

6. Demographics, Clinical Presentation, and Outcomes of Patients with Intravenous Drug Use (IVDU)-Associated Endogenous Candida Endophthalmitis
Su Jeoung Kim, MD

8:24 a.m.

7. Histopathologic Correlation between Acanthamoeba Species Recovered from Patients Who Underwent Therapeutic and Optical Penetrating Keratoplasties after Rose Bengal Photodynamic Antimicrobial Therapy
Jaime D. Martinez, MD

8:31 a.m.

8. Safety Profile of Miltefosine in Cornea and its ex vivo and in vitro Efficacy Against Acanthamoeba
Savitri Sharma, MD

8:38 a.m.

9. Patients with Neurotrophic Keratopathy Demonstrate Increased Dendritiform Cell Density and Size by in vivo Confocal Microscopy, Suggesting the Presence of Inflammation
Ana Balbuena-Pareja

8:45 a.m.

10. Characteristics of Pre-Screened Patients Who Did Not Participate in the Zoster Eye Disease Study (Zeds)
Ayodele K. Maja, BA

8:52 a.m.

11. Comparison of Pain Interference on Quality of Life in Neuropathic Corneal Pain (NCP) Patients with and without Non-ocular Facial Pain
Leyla Mirzaee, DMSc

8:59 a.m.

12. Conjunctival Optical Coherence Tomography Angiography is Associated with Ocular Redness and Corneal Dendritic Cells in Ocular Surface Disease
William Binotti, MD

9:06 a.m.

13. Chronic Inflammation as a Proposed Risk Factor for Ocular Surface Squamous Neoplasia
Sofia De Arrigunaga, MD

9:13 a.m.

14. A New Non-Contact Esthesiometer Provides Comparable Sensitivity Measurements as the Cochet-Bonnet Esthesiometer
Luiz Luciano Lamazales

9:20 a.m.

BREAK and Posters

9:40 a.m.

15. TRPV1-Dependent Corneal Resistance to Staphylococcus aureus Adhesion
Orneika Flandrin

9:47 a.m.

16. Methicillin-Resistant Staphylococcus Aureus Keratitis is Mainly Caused by Multidrug-Resistant Lineages that are Associated with Poor Outcomes
Olivia Cummings

9:54 a.m 17. Intracellular lifestyle of P. aeruginosa and Its Implications for Ofloxacin Resistance Phenotypes
Naren G. Kumar 
10:01 a.m.

18. 25-Year Analysis of Antibiotic Resistance of Pseudomonas Isolates from Ocular Samples
Derek B. Chan

10:08 a.m.

19. Association of Artificial Tears with Ocular and Systemic Infection: Carbapenem-Resistant Pseudomonas Aeruginosa (VIM-GES-CRPA) Outbreak
Frida Velcani

10:15 a.m.

20. A Novel Non Toxic Ophthalmic Preservative
Gregory Schultz, PhD

10:22 a.m.

21. Outcome of Photo Dynamic Antimicrobial therapy with Rose Bengal as an Aadjuvant Treatment in the Management of Acanthamoeba keratitis: Prospective Interventional Trial  
Rachel Wozniak, MD, PhD

10:29 a.m.

22. Activity of Cefiderocol Against Pseudomonas Aeruginosa Keratitis Isolates in vitro
Jonathan B. Mandell

10:36 a.m. 23. Cefiderocol is a Safe and Effective Topical Monotherapy for Experimental Extensively-Drug Resistant Pseudomonas Aeruginosa Keratitis
Eric G. Romanowski, MS
10:43 a.m.

24. Cefiderocol Solution is Stable at Refrigeration Temperature and Produces High Concentrations in Rabbit Corneas after Topical Therapy
Kathleen A. Yates

10:50 a.m.

25. Efficacy of a 265nm Therapeutic Ultraviolet C Beam in the Murine Model of Pseudomonas Aeruginosa Keratitis
Bhupesh Bagga, MD

10:57 a.m.

26. Use of Rose Bengal Photodynamic Therapy as a Treatment for Pseudomonas sclerokeratitis
Carolina Mercado, MD

11:04 a.m. BREAK
11:20 a.m.

Thygeson Lecture: "Gut Microbiome and Sjogren-Syndrome

Cintia S De Paiva, MD, PhD
Associate Professor
Ocular Surface Center
Cullen Eye Institute
Baylor College of Medicine
Houston, Texas

12:00 p.m. Closing Comments and Awards
12:15 p.m.

Business Luncheon - Crystal Lounge